A groundbreaking cosmetic protocol combining 3% tranexamic acid (TXA) and 5% niacinamide offers a transformative approach to managing facial hyperpigmentation. This innovative solution offers significant improvements in dark spots and skin luminosity while ensuring excellent.
- 13% reduction in dark spot intensity after 8 weeks.
- 95% of participants reported brighter, more hydrated skin.
Tranexamic Acid
Tranexamic Acid is a powerful depigmenting agent, working by inhibiting plasminogen activation, reducing melanocyte stimulation and melanin production.
Niacinamide
Niacinamide prevents melanosome transfer, enhances skin barrier function, and provides antioxidant protection, offering a comprehensive solution for pigmentation issues.
Vitamin C
Vitamin C brightens the skin by neutralizing free radicals.
Hyaluronic Acid
Hyaluronic Acid enhances hydration and absorption of active ingredients.
“Together, they deliver a potent, non-invasive alternative to traditional treatments like hydroquinone”.
Clinical Study Highlights and Expert Insights:
A clinical study conducted with 22 Caucasian participants aged 45 to 67, evaluated the safety and efficacy of a cream and serum combination. Both formulations also incorporated vitamin C and hyaluronic acid, enhancing the protocol’s brightening effects and hydrating properties.
Results demonstrated an 8% increase in skin luminosity and a 6% reduction in the size of dark spots. The study confirmed no significant adverse effects, making it a safe and effective option for individuals seeking a non-invasive approach to hyperpigmentation management.
Key findings include:
- Statistically significant improvements in dark spot intensity and size.
- High participant satisfaction, with 95% reporting enhanced skin hydration and luminosity.
- Rigorous safety assessments confirming excellent tolerability.
Learn more about the study and how this protocol can transform skincare: https://doi.org/10.3390/cosmetics11050168
